Replies to post #193669 on Biotech Values

[DewDiligence]

BIIB:

All talk about George Scangos being a top-1% biotech CEO should immediately cease.Never understood why he got a pass for screw-ups at $EXEL.

— Roy Friedman (@DewDiligence) July 24, 2015

[DewDiligence]

More color on BIIB’s bad day (with some info on phase-3 AD design):

http://www.fiercebiotech.com/story/biogen-targets-new-biotech-deals-after-reporting-sour-numbers-rd-setbacks/2015-07-24